Cargando…
The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis
Background: Advanced ovarian cancer (AOC) develops rapidly, adding to difficulties in treatment. Traditional Chinese medicine (TCM) plays a significant role in the treatment of AOC, and so to explore the efficacy and safety of TCM in the treatment of AOC and its effective targets, we performed the f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682081/ https://www.ncbi.nlm.nih.gov/pubmed/36438791 http://dx.doi.org/10.3389/fphar.2022.1040641 |
_version_ | 1784834769112006656 |
---|---|
author | Yang, Ze Wang, Xiang Hong, Wei Zhang, Shiyi Yang, Yang Xia, Yongliang Yang, Ruiwen |
author_facet | Yang, Ze Wang, Xiang Hong, Wei Zhang, Shiyi Yang, Yang Xia, Yongliang Yang, Ruiwen |
author_sort | Yang, Ze |
collection | PubMed |
description | Background: Advanced ovarian cancer (AOC) develops rapidly, adding to difficulties in treatment. Traditional Chinese medicine (TCM) plays a significant role in the treatment of AOC, and so to explore the efficacy and safety of TCM in the treatment of AOC and its effective targets, we performed the following review. Methods: The major databases were searched for randomized controlled trials of TCM for the treatment of AOC. A meta-analysis of the efficacy of Chinese herbs on AOC was conducted using RevMan 5.4 software. Active compounds and target genes were acquired using the TCMSP database. The main targets of AOC were obtained through the GenCards, OMIM, TTD, and DrugBank databases. A protein–protein interaction network carried out on the STRING platform was used to select core genes. The Metascape platform was applied to achieve GO and KEGG enrichment analysis. Results: A total of 24 studies were included. Meta-analysis shows the TCM group improved the overall response rate (OR = 2.71; 95% CI = [2.14, 3.44], Z = 8.25, p < 0.00001), overall survival (OR = 2.93, 95% CI = [2.03, 4.24], Z = 5.72, p < 0.00001), and progression-free survival (OR = 5.36, 95% CI = [5.03, 5.69], Z = 31.88, p < 0.00001) of AOC patients, as well as reducing many adverse events. There were 120 compounds, 246 herb target genes, and 1503 disease targets extracted. The 10 most important components were quercetin, kaempferol, 7-methoxy-2-methyl isoflavone, formononetin, isorhamnetin, hederagenin, stigmasterol, luteolin, 7-O-methylisomucronulatol, and calycosin. The 20 core targets were TP53, STAT3, JUN, AKT1, MAPK3, RELA, MAPK1, ESR1, IL6, FOS, MAPK14, TNF, CDKN1A, RB1, CCND1, EGFR, STAT1, MDM2, MAPK8, and CAV1. KEGG enrichment analysis showed that there are many pathways directly related to different types of tumors, such as in pathway cancer and prostate cancer. Conclusion: Our article reveals TCM is effective and safe against AOC and that Chinese herbs exert effects on the disease through multi-target, multi-component, and multi-pathway mechanisms. Systematic Review Registration: (www.crd.york.ac.uk/PROSPERO/), identifier (CRD42022369731). |
format | Online Article Text |
id | pubmed-9682081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96820812022-11-24 The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis Yang, Ze Wang, Xiang Hong, Wei Zhang, Shiyi Yang, Yang Xia, Yongliang Yang, Ruiwen Front Pharmacol Pharmacology Background: Advanced ovarian cancer (AOC) develops rapidly, adding to difficulties in treatment. Traditional Chinese medicine (TCM) plays a significant role in the treatment of AOC, and so to explore the efficacy and safety of TCM in the treatment of AOC and its effective targets, we performed the following review. Methods: The major databases were searched for randomized controlled trials of TCM for the treatment of AOC. A meta-analysis of the efficacy of Chinese herbs on AOC was conducted using RevMan 5.4 software. Active compounds and target genes were acquired using the TCMSP database. The main targets of AOC were obtained through the GenCards, OMIM, TTD, and DrugBank databases. A protein–protein interaction network carried out on the STRING platform was used to select core genes. The Metascape platform was applied to achieve GO and KEGG enrichment analysis. Results: A total of 24 studies were included. Meta-analysis shows the TCM group improved the overall response rate (OR = 2.71; 95% CI = [2.14, 3.44], Z = 8.25, p < 0.00001), overall survival (OR = 2.93, 95% CI = [2.03, 4.24], Z = 5.72, p < 0.00001), and progression-free survival (OR = 5.36, 95% CI = [5.03, 5.69], Z = 31.88, p < 0.00001) of AOC patients, as well as reducing many adverse events. There were 120 compounds, 246 herb target genes, and 1503 disease targets extracted. The 10 most important components were quercetin, kaempferol, 7-methoxy-2-methyl isoflavone, formononetin, isorhamnetin, hederagenin, stigmasterol, luteolin, 7-O-methylisomucronulatol, and calycosin. The 20 core targets were TP53, STAT3, JUN, AKT1, MAPK3, RELA, MAPK1, ESR1, IL6, FOS, MAPK14, TNF, CDKN1A, RB1, CCND1, EGFR, STAT1, MDM2, MAPK8, and CAV1. KEGG enrichment analysis showed that there are many pathways directly related to different types of tumors, such as in pathway cancer and prostate cancer. Conclusion: Our article reveals TCM is effective and safe against AOC and that Chinese herbs exert effects on the disease through multi-target, multi-component, and multi-pathway mechanisms. Systematic Review Registration: (www.crd.york.ac.uk/PROSPERO/), identifier (CRD42022369731). Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9682081/ /pubmed/36438791 http://dx.doi.org/10.3389/fphar.2022.1040641 Text en Copyright © 2022 Yang, Wang, Hong, Zhang, Yang, Xia and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yang, Ze Wang, Xiang Hong, Wei Zhang, Shiyi Yang, Yang Xia, Yongliang Yang, Ruiwen The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis |
title | The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis |
title_full | The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis |
title_fullStr | The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis |
title_full_unstemmed | The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis |
title_short | The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis |
title_sort | pharmacological mechanism of chinese herbs effective in treating advanced ovarian cancer: integrated meta-analysis and network pharmacology analysis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682081/ https://www.ncbi.nlm.nih.gov/pubmed/36438791 http://dx.doi.org/10.3389/fphar.2022.1040641 |
work_keys_str_mv | AT yangze thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT wangxiang thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT hongwei thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT zhangshiyi thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT yangyang thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT xiayongliang thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT yangruiwen thepharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT yangze pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT wangxiang pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT hongwei pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT zhangshiyi pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT yangyang pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT xiayongliang pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis AT yangruiwen pharmacologicalmechanismofchineseherbseffectiveintreatingadvancedovariancancerintegratedmetaanalysisandnetworkpharmacologyanalysis |